Literature DB >> 15838858

Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease.

Susumu Inoue, Nkechi Onwuzurike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15838858     DOI： 10.1002/pbc.20361

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  5 in total

Review 1.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

2.  Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Authors:  Philip Hahnfeldt; Lynn Hlatky; Giannoula Lakka Klement
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

3.  Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment.

Authors:  Ceyla Konca; Zübeyde N Özkurt; Müge Deger; Zeynep Akı; Münci Yağcı
Journal:  Int J Hematol       Date:  2008-11-20       Impact factor: 2.490

Review 4.  Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review.

Authors:  Birgit A Mosheimer; Bastian Oppl; Shahin Zandieh; Michael Fillitz; Felix Keil; Klaus Klaushofer; Günter Weiss; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

Review 5.  Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature.

Authors:  Francesco di Dio; Ilaria Mariotti; Elena Coccolini; Patrizia Bruzzi; Barbara Predieri; Lorenzo Iughetti
Journal:  BMC Pediatr       Date:  2016-05-03       Impact factor: 2.125
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.